Vital Chemtech Limited (VITAL) — Financial Results | 1 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Vital Chemtech Limited reported FY26 revenue of ₹126.4 crore, down 5.6% YoY, with EBITDA at ₹10.0 crore (-5.6% YoY) and PAT at ₹1.0 crore, reflecting strategic investments in subsidiaries that drove PAT margin compression to 0.8% from 3.0% in FY25, while Q4 FY26 showed stable revenue of ₹35.1 crore and 39.7% YoY EBITDA growth to ₹4.0 crore amid margin expansion.

📄 View Original Announcement (PDF)

About Vital Chemtech Limited (VITAL)

Chemicals · Chemicals · Listed on NSE

ROE: 3.3% ROCE: 5.8%

View full VITAL stock details →

📡 Get AI alerts when VITAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VITAL — Free

📊 More VITAL filings

See all VITAL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VITAL files new disclosures

Track VITAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VITAL — Free

Free account · 2 AI queries/day